Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Farmacja Polska is Scopus-indexed (Q4, CiteScore 0.3), DOAJ. Published by Polish Pharmaceutical Society.
Checked against the index lists dated .
ISSN 0014-8261Verify ISSN ↗
Publisher: Polish Pharmaceutical Society
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 49 / 57 | 14th | Q4 |
| Pharmaceutical Science | 169 / 191 | 11th | Q4 |
| Pharmacology | 306 / 328 | 6th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present (also 1995, 1985–1993, 1973–1983, 1961–1962, 1953–1955), best quartile Q4, CiteScore 0.3.
Farmacja Polska is Q4 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 49 of 57), Q4 in Pharmaceutical Science (rank 169 of 191) and Q4 in Pharmacology (rank 306 of 328), by CiteScore 2025.
Farmacja Polska is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.3, quartile Q4, 14th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.124, quartile Q4, with an H-index of 6.
The publisher lists an article processing charge of about US$124 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Farmacja Polska is published by Polish Pharmaceutical Society. Its ISSN is 0014-8261.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Farmacja Polska has an h-index of 6 and a 2-year mean of 0.14 citations per paper (OpenAlex). Its Scopus CiteScore is 0.3, quartile Q4. On 2-year citations it ranks #48 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Farmacja Polska published 54 papers in 2025; its busiest recent year was 2018 with 99. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 81 research articles (2024–2026), authors are most often from Poland (97.5%), Iraq (1.2%) and Egypt (1.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.